← Eichor
Study identifier: NCT03994874 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Peritoneal Ultrafiltration in Cardio Renal Syndrome.

Condition: Congestive Heart Failure  ·  Sponsor: Iperboreal Pharma Srl

PhasePhase 1/Phase 2
Planned participants84
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Randomized, controlled, unblinded, adaptive design clinical trial to evaluate the safety and efficacy of PolyCore (Polydextrin, L-Carnitine, D-xylitol) peritoneal ultrafiltration (PUF) in patients with heart failure and reduced ejection fraction (HFrEF).

This description comes directly from the study's public registry record.

Talk to the study team

Arduino Arduini, MD  ·  +41 79 7878312  ·  a.arduini@corequest.ch

Always discuss trial participation with your own doctor first.

Locations (3)

Ospedale Ss. AnnunziataChieti, ItalyRecruiting
ASST FBF SaccoMilan, ItalyRecruiting
Ospedale MonaldiNaples, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03994874